Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT00087802

Public ClinicalTrials.gov record NCT00087802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 10:25 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Trial of Gemcitabine/Oxaliplatin (GEMOX) Versus Carboplatin/Paclitaxel (CP) as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare combination treatment of gemcitabine + oxaliplatin (GEMOX) with carboplatin + paclitaxel (CP) to determine if there is a difference in response and safety between the two drug combinations for the treatment of advanced non-small cell lung cancer (NSCLC).

Study identification

NCT ID
NCT00087802
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
383 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2004 (Type not available)
Primary completion
May 2007 (Actual)
Completion
Not listed
Last update posted
Apr 16, 2009

Started 2004

United States locations

U.S. sites
70
U.S. states
23
U.S. cities
65
Facility City State ZIP Site status
Birmingham Hematology and Oncology Associates, LLC Birmingham Alabama 35235 —
Birmingham Hematology and Oncology Associates Birmingham Alabama 35235 —
Hematology Oncology Associates Phoenix Arizona 85012 —
Northern Arizona Hematology & Oncology Associates Sedona Arizona 86336 —
Arizona Oncology Associates - Hematology Oncology Physicians Tucson Arizona 85704 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
Florida Cancer Institute New Port Richey Florida 34652 —
Ocala Oncology Center Ocala Florida 34474 —
Cancer Centers of Florida, P.A. Ocoee Florida 34761 —
South Florida Oncology & Hematology Consultants Plantation Florida 33324 —
Hematology Oncology Associates of Illinois Chicago Illinois 60611 —
Northwest Medical Specialists, PC Niles Illinois 60714 —
Hematology Oncology Associates of Illinois Skokie Illinois 60077 —
Central Indiana Cancer Centers Indianapolis Indiana 46227 —
Oncology Associates of Cedar Rapids Cedar Rapids Iowa 52403 —
Kansas City Oncology and Hematology Group Overland Park Kansas 66210 —
Maryland Oncology Hematology, P.A. Columbia Maryland 21044 —
Berkshire Hematology Oncology, PC Pittsfield Massachusetts 01201 —
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404 —
Minnesota Oncology Hematology Minneapolis Minnesota 55404 —
Missouri Cancer Associates Columbia Missouri 65201 —
Arch Medical Services, Inc. St Louis Missouri 63141 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109 —
New Mexico Cancer Care Associates Santa Fe New Mexico 87505 —
New York Oncology Hematology, P.C. Albany New York 12208 —
New York Oncology Hematology Latham New York 12110 —
New York Oncology Hematology, P.C. Rexford New York 12148 —
Interlakes Oncology & Hematology, P.C. Rochester New York 14623 —
Raleigh Hematology Oncology Clinic Cary North Carolina 27511 —
Piedmont Hematology Oncology Associates, PLLC. Winston-Salem North Carolina 27103 —
Dayton Oncology & Hematology, P.A. Kettering Ohio 45409 —
Cancer Care Associates Oklahoma City Oklahoma 73120 —
Cancer Care Associates Tulsa Oklahoma 74136-1902 —
Willamette Valley Cancer Center Eugene Oregon 97401 —
Cancer Centers of the Carolinas Seneca South Carolina 29672 —
Texas Cancer Center - Abilene Abilene Texas 79606 —
Texas Oncology, P.A. Arlington Texas 76012 —
Texas Oncology Cancer Center Austin Texas 78731 —
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702-1449 —
Texas Oncology, P.A. Bedford Texas 76022 —
Texas Cancer Center at Medical City Dallas Texas 75230-2510 —
Texas Oncology, P.A. Dallas Texas 75231 —
The Texas Cancer Center Dallas Texas 75237 —
Texas Oncology, P.A. Dallas Texas 75246 —
Texas Cancer Center - Denton Denton Texas 76210 —
El Paso Cancer Treatment Ctr-East El Paso Texas 79915 —
Texas Oncology, P.A. Fort Worth Texas 76104 —
San Antonio Tumor and Blood Clinic Fredericksburg Texas 78624 —
Texas Oncology, P.A. Garland Texas 75042-5788 —
Texas Oncology, P.A. Houston Texas 77024 —
Texas Oncology, P.A. Irving Texas 75061-2244 —
Lake Vista Cancer Center Lewisville Texas 75067 —
Longview Cancer Center Longview Texas 75601 —
South Texas Cancer Center - McAllen McAllen Texas 78503-1298 —
Texas Cancer Center of Mesquite Mesquite Texas 75150 —
Allison Cancer Center Midland Texas 79701-5946 —
West Texas Cancer Center Odessa Texas 79761 —
Paris Regional Cancer Center Paris Texas 75460 —
Hematology Oncology Associates of South Texas San Antonio Texas 78229 —
Texas Cancer Center - Sherman Sherman Texas 75090-0504 —
Tyler Cancer Center Tyler Texas 75702 —
Waco Cancer Care and Research Center Waco Texas 76712 —
Deke Slayton Cancer Center Webster Texas 77598 —
Fairfax Northern Virginia Hematology Oncology, PC Fairfax Virginia 22031 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Oncology & Hematology Associates of Southwest Virginia, Inc. Salem Virginia 24153 —
Puget Sound Cancer Centers Edmonds Washington 98026 —
Puget Sound Cancer Centers Seattle Washington 98133 —
Cancer Care Northwest Spokane Washington 99218 —
Northwest Cancer Specialists, P.C. Vancouver Washington 98684 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2009 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00087802 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →